Conference
A phase II study of patupilone in patients with metastatic hormone refractory prostate cancer (HRPC) who have progressed after docetaxel
Authors
Chi KN; Beardsley EK; Venner PM; Eigl BJ; Hotte SJ; Ko Y; Saad F; Winquist E
Volume
26
Pagination
pp. 5166-5166
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2008
DOI
10.1200/jco.2008.26.15_suppl.5166
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X